SYNTHORX Trademark

Trademark Overview

On Tuesday, July 9, 2019, a trademark application was filed for SYNTHORX with the United States Patent and Trademark Office. The USPTO has given the SYNTHORX trademark a serial number of 88505851. The federal status of this trademark filing is REGISTERED as of Tuesday, February 7, 2023. This trademark is owned by Synthorx, Inc.. The SYNTHORX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

medical research; scientific research in the field of DNA; pharmaceutical research and development; laboratory research services in the field of pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology, proteomics, and veterinary medicine and diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, res...
synthorx

General Information

Serial Number88505851
Word MarkSYNTHORX
Filing DateTuesday, July 9, 2019
Status700 - REGISTERED
Status DateTuesday, February 7, 2023
Registration Number6974848
Registration DateTuesday, February 7, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesmedical research; scientific research in the field of DNA; pharmaceutical research and development; laboratory research services in the field of pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology, proteomics, and veterinary medicine and diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents
Description of MarkThe mark consists of the term "SYNTHORX" in stylized font with a double helix design within the "O" in "SYNTHORX".

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 17, 2019
Primary Code042
First Use Anywhere DateWednesday, November 9, 2022
First Use In Commerce DateWednesday, November 9, 2022

Trademark Owner History

Party NameSynthorx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameSynthorx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameSynthorx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Friday, July 12, 2019NEW APPLICATION ENTERED
Wednesday, July 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 18, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, September 25, 2019ASSIGNED TO EXAMINER
Thursday, September 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 7, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 7, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 10, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 10, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 9, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020SOU EXTENSION 1 FILED
Tuesday, June 9, 2020SOU EXTENSION 1 GRANTED
Thursday, June 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 3, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 3, 2020SOU EXTENSION 2 FILED
Tuesday, November 3, 2020SOU EXTENSION 2 GRANTED
Thursday, November 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 5, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 5, 2021SOU EXTENSION 3 FILED
Wednesday, May 5, 2021SOU EXTENSION 3 GRANTED
Friday, May 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 10, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, November 10, 2021SOU EXTENSION 4 FILED
Wednesday, November 10, 2021SOU EXTENSION 4 GRANTED
Friday, November 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 1, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 1, 2022SOU EXTENSION 5 FILED
Tuesday, June 7, 2022SOU EXTENSION 5 GRANTED
Wednesday, June 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 1, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, December 1, 2022USE AMENDMENT FILED
Wednesday, December 7, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 4, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 5, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 7, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, February 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 2, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 2, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 2, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 2, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 2, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 2, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

synthorx research pharmaceutical field including pharmaceuticals medical namely synthetic development oncology